'김갑성' 기자의 전체기사
-
Jacobio Pharma Announces 2025 Interim Results
BEIJING and SHANGHAI and BOSTON, Aug. 30, 2025 -- Jacobio Pharma (1167.HK) today announced its interim results for the six months ended June 30, 2025. During the reporting period, the Company achieved revenue of RMB45.7 million, representing a 100% increase compared with the same period in 2024. Research and development (R&D) expenses amounted to RMB93.2 million. The net loss for the first half of 2025 was RMB59.0 million, narrowing by 65.1% compared with the same period in 2024. As of June 30, 2025, Jacobio maintained cash and bank balances, and investments in capital protected
- 김갑성 기자
- 2025-08-30 00:25
-
Medtronic executives to speak at upcoming investor confe…
GALWAY, Ireland, Aug. 29, 2025 -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday, September 4, 2025, at 8:00 a.m. EDT (7:00 a.m. CDT)Geoff Martha, Medtronic chairman and chief executive officer, and Thierry Piéton, Medtronic executive vice president and chief financial officer, will answer questions on the company. Morgan Stanley 23rd Annual Global Healthcare ConferenceMonday, September 8, 2025, at 4:50 p.m. EDT (3:50 p.m.
- 김갑성 기자
- 2025-08-29 23:51
-
Lifezoom Updates: Refining Efficient Light Therapy Product…
NEW YORK, Aug. 29, 2025 -- Since its launch, Lifezoom's light therapy devices have steadily become a promising contender in the industry. However, users' feedback revealed that the original single blue light mode is primarily suitable for short-term use, which highlights the limited benefits of blue light, with most customers calling for higher efficiency at specific wavelengths. As Lifezoom's CEO mentioned, "User feedback is our most important guide. In this instance, we acted quickly to enhance the red light wand, reflecting Lifezoom's core philosophy of putting user needs at th
- 김갑성 기자
- 2025-08-29 23:21
-
United Imaging Healthcare Reports 2025H1 Financial Results:…
SHANGHAI, Aug. 29, 2025 -- United Imaging Healthcare (SSE: 688271), a global leader in advanced medical imaging and radiotherapy equipment, has released its financial results for the first half of 2025, maintaining steady growth. The company's revenue and net profit attributable to ordinary shareholders after deducting non-recurring profit or loss reached CNY 6.02 billion and 0.97 billion for 2025H1, representing a year-over-year increase of 12.79% and 21.01% respectively. The company's revenue growth was primarily fueled by continuous launch of innovative high-end products, now widely
- 김갑성 기자
- 2025-08-29 20:00
-
YD Bio Limited Announces Closing of Business Combination…
[ 메디채널 김갑성 기자 ] Strategic Move Positions YD Bio Limited for Accelerated Innovation and Market Expansion Trading of common stock and warrants of the new public company, YD Bio Limited, is expected to commence on the Nasdaq Global Market on August 29, 2025, under the ticker symbols "YDES" and "YDESW" NEW YORK, Aug. 29, 2025 -- YD Bio Limited ("YD Bio Ltd" or the "Company") (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced the successful completio
- 김갑성 기자
- 2025-08-29 19:30
-
Arclin Enters into Definitive Agreement to Acquire Aramids Busin…
Acquired brands to broaden and complement Arclin's innovation platform ALPHARETTA, Ga., Aug. 29, 2025 -- Arclin announced today it has entered into a definitive agreement to acquire DuPont's Aramids business, which includes the Kevlar® and Nomex® brands, for approximately $1.8 billion. The planned acquisition will expand Arclin's portfolio to include aerospace, electrical infrastructure, electric vehicles, personal protection, and defense, while building on its strong positions in construction, infrastructure, weather and fire protection, and transportation. Arclin's cu
- 김갑성 기자
- 2025-08-29 19:01
-
Taiwan's Smart Healthcare Pavilion Presents Precision Onco…
DALLAS, Aug. 29, 2025 -- At Taiwan Expo USA 2025 in Dallas, the Smart Healthcare Pavilion, organized by the International Trade Administration (TITA) and the Taiwan External Trade Development Council (TAITRA), highlighted Taiwan's accelerating role in global digital health innovation. The pavilion brought together leading organizations introducing new approaches across telemedicine, artificial intelligence (AI), precision medicine, and next-generation medical services, as reported by GeneOnline. One key highlight was CancerFree Biotech Ltd., which has advanced precision oncolog
- 김갑성 기자
- 2025-08-29 17:32
-
MGI Tech and JCBio Announce Collaboration on DCS Lab Pro…
CHANGCHUN, China, Aug. 29, 2025 -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and JCBio Co., Ltd. ("JCBio"), a leading South Korean biotechnology company, have signed a Memorandum of Understanding (MoU) to launch the DCS Lab Project, a landmark collaboration. The initiative aims to accelerate multi-omics research, novel sequencing applications, precision medicine, clinical translation, and AI-driven data insights in South Korea. By combining MGI's advanced omics technologies with
- 김갑성 기자
- 2025-08-29 17:29
-
Gateway to Growth: Innovation and Opportunity at the 8th CIIE
SHANGHAI, Aug. 29, 2025 -- Amid a shifting global economy, the China International Import Expo (CIIE) continues to provide a vital gateway for global enterprises. With preparations for the 8th CIIE well underway, the expo is set to once again showcase innovation, foster cooperation, and expand access to the Chinese dynamic market. Leveraging the vital platform for global enterprises to access the Chinese massive market, many exhibitors have grown from participants into investors, while numerous exhibits have been transformed into marketable goods. Novartis, for instance, debute
- 김갑성 기자
- 2025-08-29 16:44
-
UCB presents latest research and clinical advancement ac…
[ 메디채널 김갑성 기자 ] 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning in children and adults with Dravet syndrome or Lennox-Gastaut syndrome[2] Data provide insights on developmental and epileptic encephalopathies (DEEs), including a qualitative study addressing diagnostic challenges and benefits in adult care settings, and a caregiver survey exploring the dai
- 김갑성 기자
- 2025-08-29 14:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-19_SUN
- Significant OS Benefit with Cadonilimab in First-Line Advanced Gastric Cancer: Final Analysis of COMPASSION-15 Presented at ESMO 2025 23:42
- HARMONi-6 Data: mPFS 11.14 Months (HR=0.6, P<0.0001) Simultaneously Released at ESMO and in The Lancet 23:37
- United Imaging Marks Five Years Since the Opening of its Global Showroom In North America with a Record Number of U.S. Customer Visits 22:00
- Multitude Therapeutics Announces Encouraging Interim Phase I/II Results from Ongoing First-in-Human Study Evaluating its MUC18-directed Antibody-Drug-Conjugate, AMT-253, in Melanoma and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting 15:00
- Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia 14:00
- From Wellbeing to Academics: Why HK Parents Are Hitting Pause on Kids' Social Media and Device Use 13:00
- 내면의 조화를 발견하세요: '원더풀 인도네시아 웰니스 페스티벌 2025' 개최 01:50
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 20일 01시 20분